News & Updates

Infertile women may benefit from oil-based contrast during HSG

01 Aug 2024 by

Hysterosalpingography (HSG) with an oil-based contrast medium yields a significantly higher rate of ongoing pregnancy and live birth than HSG with a water-soluble contrast medium, according to a study presented at ESHRE 2024.

Infertile women may benefit from oil-based contrast during HSG

01 Aug 2024

Hydroxychloroquine a promising treatment option for anogenital lichen sclerosus

31 Jul 2024

In the treatment of patients with anogenital lichen sclerosus, the use of hydroxychloroquine appears to induce favourable response rates with low incidence of adverse effects, as shown in a retrospective study.

Hydroxychloroquine a promising treatment option for anogenital lichen sclerosus

31 Jul 2024

Vaginal hyaluronic acid matches up to oestrogen for relieving GSM

31 Jul 2024 by

In the treatment of genitourinary syndrome of menopause (GSM), the nonhormone alternative vaginal hyaluronic acid is equally efficacious as the treatment standard vaginal oestrogen, while being well-tolerated, as shown in a pilot study.

Vaginal hyaluronic acid matches up to oestrogen for relieving GSM

31 Jul 2024

Is it unsafe to use GLP-1 RAs in early pregnancy?

31 Jul 2024 by

Exposure to GLP-1 receptor agonist (RA) treatment during early pregnancy does not appear to increase the risk of complications in pregnant women, as shown in a study presented at ESHRE 2024.

Is it unsafe to use GLP-1 RAs in early pregnancy?

31 Jul 2024

Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer

31 Jul 2024

Treatment with antiplatelet medications and age are some of the factors associated with the occurrence of radiation proctitis in patients with locally advanced cervical cancer treated by chemoradiation, a recent study has shown.

Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer

31 Jul 2024

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

31 Jul 2024

A more selective risk-based approach to an enoxaparin thromboprophylaxis protocol appears to reduce the incidence of wound hematomas without increasing the rates of postpartum venous thromboembolism (VTE), as shown in a retrospective study.

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

31 Jul 2024

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

30 Jul 2024 by

The addition of dostarlimab to a carboplatin-paclitaxel (CP) chemotherapy regimen confers an overall survival (OS) benefit in women with primary advanced or recurrent endometrial cancer (EC), according to the second interim analysis of the ENGOT-EN6/GOG-3031/RUBY trial part 1.

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

30 Jul 2024

Dual-function hydrogel implant helps stop endometriosis, pregnancy

29 Jul 2024 by

A novel, stimuli-responsive hydrogel implant for reversible occlusion of the fallopian tubes holds promise for preventing pregnancy and endometriosis or halting the latter’s spread, as reported in a study.

Dual-function hydrogel implant helps stop endometriosis, pregnancy

29 Jul 2024

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024 by

Dual triggering with gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) was not superior to GnRHa alone in terms of mature oocyte retrieval for elective fertility preservation, according to a study presented at ESHRE 2024.

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

27 Jul 2024

Menopause linked to bladder woes

26 Jul 2024

Overactive bladder (OAB) is common among women undergoing menopause, especially among those at late menopausal stage and who have other menopausal symptoms, as reported in a cross-sectional study.

Menopause linked to bladder woes

26 Jul 2024

News & Updates

Filter by Specialty:

Specialty:

Infertile women may benefit from oil-based contrast during HSG

Infertile women may benefit from oil-based contrast during HSG

Hydroxychloroquine a promising treatment option for anogenital lichen sclerosus

Hydroxychloroquine a promising treatment option for anogenital lichen sclerosus

Vaginal hyaluronic acid matches up to oestrogen for relieving GSM

Vaginal hyaluronic acid matches up to oestrogen for relieving GSM

Is it unsafe to use GLP-1 RAs in early pregnancy?

Is it unsafe to use GLP-1 RAs in early pregnancy?

Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer

Anticoagulant use, older age predict radiation proctitis in chemoradiation-treated cervical cancer

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

Selective enoxaparin protocol lowers hematoma rates without compromising VTE protection

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

RUBY update: Dostarlimab strengthens spot in the endometrial cancer treatment arena

Dual-function hydrogel implant helps stop endometriosis, pregnancy

Dual-function hydrogel implant helps stop endometriosis, pregnancy

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Dual trigger as good as GnRHa alone trigger for mature oocyte retrieval

Menopause linked to bladder woes

Menopause linked to bladder woes